Bionaxe and EArnold intend to develop and commercialize proprietary technologies and methodologies that will advance manufacturing within the materials sciences through improved process management and integration. The development of critical additive technologies will enable the application of patended Bionaxe technologies and processes. Further research programmes may follow.

Bionaxe will bear primary responsibility for process design and development, and for laboratory testing, manufacturing and integration.

EArnold brings extensive world-wide access to key partners and customers.


For more information, contact:
Allista Sterling, CEO.